Previous 10 | Next 10 |
home / stock / mrvl / mrvl articles
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Veeva Systems Inc. (NYSE: VEEV) is a buy, even though it’s a "h...
Last night, Reuters reported that OpenAI has been exploring the options of building its own AI accelerator and diversifying its suppliers...
Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 10 years by 7.27% on an annualized basis producing an average annual return of...
Benzinga Weekly Jobless Claims Unexpectedly Fall 20K To 201K Weekly Initial Jobless Claims were 201,000, a decrease of 20,000 from the previo...
Broadcom Inc (NASDAQ: AVGO) stock is trading lower Thursday amid reports of Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) Google&...
An in-line Federal Reserve decision failed to boost market sentiment, leading to negative signals in index futures on Thursday. Small-cap and tech ...
Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 20 years by 1.32% on an annualized basis producing an average annual return of...
Geopolitical tensions may rise in the upcoming weeks due to strengthening alliances. As the U.S. and Vietnam forge closer strategic ties, Russia an...
Marvell Tech (NASDAQ:MRVL) has outperformed the market over the past 5 years by 12.98% on an annualized basis producing an average annual return of...
News, Short Squeeze, Breakout and More Instantly...
Marvell Technology Inc. Company Name:
MRVL Stock Symbol:
NASDAQ Market:
Marvell Technology Inc. Website:
Calgary, Alberta--(Newsfile Corp. - July 19, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the " Company " or " Marvel "), is pleased to report that, further to its press releases of May 16, 2024 and June 21, 2024, it has ...
2024-07-15 18:00:00 ET Broadcom (NASDAQ: AVGO) and Marvell Technology (NASDAQ: MRVL) usually don't attract as much attention as higher-growth chipmakers like Nvidia (NASDAQ: NVDA) . But like Nvidia, both diversified chip specialists are benefiting from the rapid ...
Calgary, Alberta--(Newsfile Corp. - July 9, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased to highlight the recently published paper "Neuronal A2A receptor exacerbate...